Assistant Professor of Genetics and Developmental Biology Stormy Chamberlain holds a tray of stem cells at the University of Connecticut`s Stem Cell Institute at the UConn Health Center .Pharmaceutical giant Bayer just made an investment through its investment arm Leaps by Bayer in Khloris, a company looking to use stem cell-based vaccines to prevent and treat cancer.
Khloris is working to see if it's possible to reintroduce stem cells — cells that aren't yet specialized — into the body to jump-start the immune system and knock out a person's cancer, or prevent a particular cancer from occurring in the first place. Juergen Eckhardt, who heads up Leaps by Bayer, told Business Insider that the hope is to get the treatment into human trials in 2020.
Bayer is making a bet that an experimental kind of vaccine could one day treat or maybe even prevent cancer., the investment arm within the life sciences and pharmaceutical giant that's focused on finding and funding breakthroughs, just made an investment in Khloris, a company founded in 2017 using technology spun out of Stanford University to explore the use of stem cells as a way to one day treat or prevent cancer. The financial terms of the investment were not disclosed.
Good news, but if so let’s see if it’s with a Democratic price tag & not just for few who can afford it. The weak tends to get downtrodden by Giants.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: BusinessInsider - 🏆 729. / 51 Read more »